Zendal launches its line of probiotics with a capital injection in its subsidiary Bialactis Biotech
The Zendal group has decided to strengthen its business line of pharmaceutical-quality probiotics with a capital injection for the “ambitious international expansion plan” of its Porriño-based subsidiary Bialactis. According to…